Q&A with David Milan from Massachusetts General Hospital: Research Helps Raise Awareness for Fibromusclar Dysplasia

Video

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

David J. Milan, MD, from Massachusetts General Hospital discussed research that is being done for the condition during the American Heart Association's annual meeting in Orlando.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
A panel of 5 cardiovascular experts
Video 5 - "Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice" - Featuring 1 KOL
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
© 2024 MJH Life Sciences

All rights reserved.